Routine

Recurrent nephrolithiasis — metabolic work-up and prevention

stone prevention · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Structured evaluation and prevention for recurrent or high-risk kidney stone formers, driven by stone composition and a 24-hour urine metabolic profile. High fluid intake and targeted dietary/pharmacological measures markedly reduce recurrence.

Red flags

  • Stones with fever/sepsis (infected obstruction) — emergency
  • Bilateral obstruction or solitary kidney obstruction
  • Nephrocalcinosis or rapidly growing staghorn stone
  • Hypercalcaemia (consider primary hyperparathyroidism)
  • Rapidly recurrent stones in a child or young adult

Assessment

Differential diagnosis

  • Calcium oxalate stones
  • Calcium phosphate stones
  • Uric acid stones
  • Struvite (infection) stones
  • Cystine stones
  • Secondary causes (primary hyperparathyroidism, distal RTA, enteric hyperoxaluria)

Investigations

  • Stone analysis (composition) — the most informative test
  • Two 24-hour urine collections (volume, calcium, oxalate, citrate, uric acid, sodium, pH, cystine)
  • Serum calcium, phosphate, PTH, bicarbonate, urate, creatinine
  • Urinalysis and urine culture (pH, infection)
  • Non-contrast CT KUB to assess stone burden
  • Fasting urine pH and morning pH profile (RTA/uric acid clues)

Management

  • Identify high-risk/recurrent formers warranting full metabolic evaluation (multiple stones, young age, solitary kidney, non-calcium stones, family history)
  • Analyse the stone to direct therapy
  • Collect at least one (ideally two) 24-hour urine samples on the patient's usual diet
  • Screen for secondary causes: hyperparathyroidism (high Ca/PTH), distal RTA (high urine pH, low citrate), enteric hyperoxaluria
  • Advise fluid intake to achieve urine output >2.5 L/day as the universal first step
  • Reduce dietary sodium (<2 g/day) and animal protein; maintain normal dietary calcium (do not restrict)
  • For hypercalciuria add a thiazide diuretic to lower urinary calcium
  • For low citrate or uric acid/cystine stones give potassium citrate to alkalinise urine and raise citrate
  • For uric acid stones alkalinise urine to pH 6.5-7 and add allopurinol if hyperuricosuria/hyperuricaemia
  • For hyperoxaluria reduce oxalate intake, ensure calcium with meals; treat enteric cause
  • Treat struvite stones with complete stone removal plus infection control
  • Repeat 24-hour urine at 3-6 months to confirm metabolic response and adjust therapy

Drugs & doses

Potassium citrate 10-20 mEq PO two to three times daily (hypocitraturia, uric acid/cystine stones)
Hydrochlorothiazide 25 mg PO daily OR indapamide 2.5 mg PO daily (hypercalciuria)
Allopurinol 100-300 mg PO daily (uric acid stones / hyperuricosuria)
Tiopronin 100-300 mg PO three times daily (cystine stones, if citrate insufficient)
Pyridoxine 100-300 mg PO daily (selected primary hyperoxaluria)

Disposition

Outpatient stone/metabolic clinic with urology and dietitian input. Urology/emergency referral for obstructing or infected stones.

Complications & pitfalls

  • Obstructive uropathy and AKI
  • Recurrent urosepsis
  • Progressive CKD from recurrent obstruction/nephrocalcinosis
  • Staghorn calculi and kidney loss
  • Medication side effects (hypokalaemia with thiazide, GI with citrate)

Exam pearls

  • Stone composition analysis is the single most useful investigation
  • Do NOT restrict dietary calcium — normal calcium with meals binds oxalate
  • Target urine output >2.5 L/day — the cheapest effective intervention
  • Low urine citrate and low urine pH point to distal RTA
  • Thiazides lower urinary calcium; potassium citrate raises citrate and pH

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.